Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Cottini

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|July 12, 2025
Small Airway Dysfunction Is an Independent Exacerbation Risk Biomarker in the Mild, Well-Controlled Patient With Asthma: A Frequently Unrecognized High-Risk PhenotypeStanley P Galant, Marcello Cottini, Alvise Berti, et al.
Frontiers in Medicine|June 9, 2022
Small Airways: The "Silent Zone" of 2021 GINA Report?Marcello Cottini, Carlo Lombardi, Giovanni Passalacqua, et al.
Chest|December 29, 2024
Ascertainment of Small Airways Dysfunction Using Oscillometry to Better Define Asthma Control and Future Risk: Are We Ready to Implement It in Clinical Practice?Rory Chan, Laura Gochicoa-Rangel, Marcello Cottini, et al.
Drugs|June 7, 2024
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the LifespanCarlo Lombardi, Pasquale Comberiati, Erminia Ridolo, et al.
Drugs|February 22, 2025
Correction: Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the LifespanCarlo Lombardi, Pasquale Comberiati, Erminia Ridolo, et al.
Drugs in Context|May 5, 2025
Switching from multiple-inhaler triple therapy to single, extrafine-inhaler triple therapy in severe refractory asthma with EGPA: beyond control. Case report and review of the literatureFrancesco Menzella, Marcello Cottini, Silvia Tonin, et al.
Respiratory Medicine|March 27, 2025
A real-world study on tezepelumab effectiveness in severe asthma focusing on small airway dysfunctionFrancesco Menzella, Marcello Cottini, Carlo Lombardi, et al.
Journal of Clinical Medicine|April 14, 2026
Dual Remission in Patients with Moderate-to-Severe Asthma and CRSwNP Treated with Dupilumab: A 24-Month Real-World StudyFrancesco Menzella, Alvise Berti, Walter Cestaro, et al.
Respiratory Medicine|August 18, 2023
Impulse oscillometry defined small airway dysfunction in asthmatic patients with normal spirometry: Prevalence, clinical associations, and impact on asthma controlMarcello Cottini, Benedetta Bondi, Diego Bagnasco, et al.
Current Research in Immunology|September 21, 2021
Immune and cellular damage biomarkers to predict COVID-19 mortality in hospitalized patientsCarlo Lombardi, Elena Roca, Barbara Bigni, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Allergy and Clinical Immunology. in Practice|July 12, 2025
Small Airway Dysfunction Is an Independent Exacerbation Risk Biomarker in the Mild, Well-Controlled Patient With Asthma: A Frequently Unrecognized High-Risk PhenotypeStanley P Galant, Marcello Cottini, Alvise Berti, et al.
Frontiers in Medicine|June 9, 2022
Small Airways: The "Silent Zone" of 2021 GINA Report?Marcello Cottini, Carlo Lombardi, Giovanni Passalacqua, et al.
Chest|December 29, 2024
Ascertainment of Small Airways Dysfunction Using Oscillometry to Better Define Asthma Control and Future Risk: Are We Ready to Implement It in Clinical Practice?Rory Chan, Laura Gochicoa-Rangel, Marcello Cottini, et al.
Drugs|June 7, 2024
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the LifespanCarlo Lombardi, Pasquale Comberiati, Erminia Ridolo, et al.
Drugs|February 22, 2025
Correction: Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the LifespanCarlo Lombardi, Pasquale Comberiati, Erminia Ridolo, et al.
Drugs in Context|May 5, 2025
Switching from multiple-inhaler triple therapy to single, extrafine-inhaler triple therapy in severe refractory asthma with EGPA: beyond control. Case report and review of the literatureFrancesco Menzella, Marcello Cottini, Silvia Tonin, et al.
Respiratory Medicine|March 27, 2025
A real-world study on tezepelumab effectiveness in severe asthma focusing on small airway dysfunctionFrancesco Menzella, Marcello Cottini, Carlo Lombardi, et al.
Journal of Clinical Medicine|April 14, 2026
Dual Remission in Patients with Moderate-to-Severe Asthma and CRSwNP Treated with Dupilumab: A 24-Month Real-World StudyFrancesco Menzella, Alvise Berti, Walter Cestaro, et al.
Respiratory Medicine|August 18, 2023
Impulse oscillometry defined small airway dysfunction in asthmatic patients with normal spirometry: Prevalence, clinical associations, and impact on asthma controlMarcello Cottini, Benedetta Bondi, Diego Bagnasco, et al.
Current Research in Immunology|September 21, 2021
Immune and cellular damage biomarkers to predict COVID-19 mortality in hospitalized patientsCarlo Lombardi, Elena Roca, Barbara Bigni, et al.
Pageof 5